Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray
The autoantibody in patients’ serum can act as a biomarker for diagnosing cancer, and the differences in autoantibodies are significantly correlated with the changes in their target proteins. In this study, 16 renal cancer (RC) patients were assigned to the disease group, and 16 healthy people were...
Main Authors: | Sun Yangyang, Liu Chengxi, Zhong Huidong, Wang Chenguang, Xu Haibo, Chen Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
China Science Publishing & Media Ltd.
2022-12-01
|
Series: | Acta Biochimica et Biophysica Sinica |
Subjects: | |
Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2022189 |
Similar Items
-
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
by: Qian Yang, et al.
Published: (2023-05-01) -
Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus
by: Honglin Zhu, et al.
Published: (2015-08-01) -
Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt™ proteome microarray
by: Wenjuan Fan, et al.
Published: (2022-10-01) -
Microarray ELISA for Autoantibody Screening in Connective Tissue Diseases
by: Sarita Kumble, et al.
Published: (2012-04-01) -
Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency
by: Jacob Michael Rosenberg, et al.
Published: (2015-04-01)